ENZYGNOST F 1+2
FDA 510(k) clearance K922934 · decided 1992-11-16
Clearance details
- K-number
- K922934
- Device name
- ENZYGNOST F 1+2
- Applicant
- Behring Diagnostics, Inc.
- Decision
- Substantially Equivalent
- Date received
- 1992-06-18
- Decision date
- 1992-11-16
- Days to decision
- 151 days
- Clearance type
- Traditional
- Product code
- MIF
- Device class
- 2
- Regulation number
- 864.7320
- Medical specialty
- Hematology
- Advisory committee
- Hematology
- Location
- Somerville, NJ, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Behring Diagnostics
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
| Record | Firm | Date |
|---|---|---|
| ENZYGNOST F+2 (MONOCLONAL) TEST KIT (K042687) | Dade Behring, Inc. | 2004-12-10 |
| THROMBONOSTIKA F1.2 (K964934) | Organon Teknika Corp. | 1997-03-18 |
| TPP (K962176) | Panbio, Inc. | 1996-10-18 |
| DADE(R) PROTHROMBIN FRAGMENT F1.2 ELISA (K920895) | Baxter Diagnostics, Inc. | 1992-06-04 |
| THROMBONOSTIKA F1.2 (K911434) | Organon Teknika Corp. | 1991-10-31 |
Recalls involving this device
No recalls on record reference this clearance.
PMA approvals by this applicant
| Record | Firm | Date |
|---|---|---|
| OPUS(R) CEA TEST SYSTEM (P920021/S001) | Behring Diagnostics, Inc. | 1996-02-23 |